Evidence map›Paper›PMID 25120829›Full record

ReviewInternational journal of clinical and experimental pathology2014

Sarcoidal granulomas in the mediastinal lymph nodes after treatment for marginal zone lymphoma of the esophagus: report of a case with review of the concept of the sarcoidosis-lymphoma syndrome.

Mitsuaki Ishida, Keiko Hodohara, Aya Furuya, Hiroko Okuno, Miyuki Yoshii, Akiko Horinouchi, Ayaka Shirakawa, Muneo Iwai, Akiko Kagotani, Takashi Yoshida

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Sarcoid-like reaction in cases treated by checkpoint inhibitors.Medical oncology (Northwood, London, England) · 2021
    Review
  5. Sarcoidosis and breast cancer: A retrospective case series.Respiratory medicine case reports · 2020
    Article
  6. Article
  7. Pembrolizumab reactivates pulmonary granulomatosis.Respiratory medicine case reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mitsuaki IshidaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan ; Division of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Keiko HodoharaDepartment of Hematology, Shiga University of Medical Science Shiga, Japan.
Aya FuruyaDepartment of Hematology, Shiga University of Medical Science Shiga, Japan.
Hiroko OkunoDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Miyuki YoshiiDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Akiko HorinouchiDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Ayaka ShirakawaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Muneo IwaiDivision of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Akiko KagotaniDivision of Diagnostic Pathology, Shiga University of Medical Science Shiga, Japan.
Takashi YoshidaDepartment of Clinical Laboratory Medicine, Shiga University of Medical Science Shiga, Japan.
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with sarcoidosis have a high risk of development of malignant lymphoma, and this association was coined the term "sarcoidosis-lymphoma syndrome". Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is a distinct clinicopathological entity, and the stomach is the most common site. The occurrence of this type of lymphoma in the esophagus is extremely rare. In this report, we describe the first documented case of sarcoidal granulomas in the mediastinal lymph nodes after treatment for MALT lymphoma of the esophagus. A 60-year-old Japanese female was found to have a submucosal tumor in the esophagus. Histopathological study revealed proliferation of small- to medium-sized lymphoid cells with convoluted nuclei, and immunohistochemically, these lymphoid cells were diffusely positive for CD20, bcl-2, and MUM1. R-CHOP therapy was performed, which led to tumor remission. Two years later, swelling of the mediastinal lymph nodes was detected. Histopathological study of the lymph nodes revealed presence of variably-sized epithelioid granulomas without caseating necrosis but no malignant lymphoma was noted. Sarcoidal granulomas can be observed in patients with malignant tumors including malignant lymphoma and carcinoma without history of systemic sarcoidosis. It is important to recognize that systemic sarcoidosis and sarcoidal reaction without evidence of systemic disease can occur after development of malignant lymphoma, therefore, sarcoidal reaction must be included in the differential diagnostic consideration of recurrent malignant lymphoma.

Indexed as

Antibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCyclophosphamideDoxorubicinEsophageal NeoplasmsFemaleGranulomaHumansImmunohistochemistryLymph NodesLymphoma, B-Cell, Marginal ZoneMiddle AgedPrednisoneRituximabSarcoidosisAntibodies, Monoclonal, Murine-DerivedBiomarkers, TumorCyclophosphamideDoxorubicinPrednisoneR-CHOP protocolRituximabVincristineesophagusmarginal zone lymphomaSarcoidosissarcoidosis-lymphoma syndrome

Identifiers

PMID25120829
PMCPMC4129064
OpenAlexW1683676939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.